Teva Pharma (NYSE: TEVA) is fractionally higher Tuesday as an opportunity may have emerged from Bristol-Myers Squibb's (NYSE: BMY) setback ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE